TIL

5.2305.77%
GM

George Matcham

Independent Non-Employee Director

Dr. George Matcham, Ph.D. was a Non-Executive Director at Chimeric Therapeutics Limited since July 05, 2021 until 3 August 2023. Dr. Matcham is a Non-Employee Director and advisor at Instil Bio, Inc. since September 2018. He joined Celgene in its infancy in 1988. At Celgene, Dr. Matcham championed the introduction of cellular immunotherapy and led the establishment of cell therapy and biologics technical development. Vital to the growth of cell therapy at Celgene, Dr. Matcham held several senior positions, including Chief Operations Officer of Celgene Cellular Therapeutics and Senior Vice President of CAR T CMC & Technology Development, from August 2017 to June 2018 and Senior Vice President, Biologics Development and Manufacturing from May 2013 to August 2017, with responsibility for CAR T CMC & Manufacturing from September 2015, where he oversaw clinical supply. Dr. Matcham received his B.Sc. and Ph.D. in biochemistry from Cardiff University. He holds M.A from the prestigious Cambridge University.

Positions